Eos SENOLYTIX, .Eos SENOLYTIX, .
Eos SENOLYTIX, .

Eos SENOLYTIX, .

Develops senolytic drugs to clear senescent cells and promote cellular rejuvenation.

Website
2017Active
Advertise here

About

Eos SENOLYTIX is a longevity biotechnology company developing novel gerotherapeutics that target the fundamental mechanisms of aging. Their lead candidate, PTC-2105, utilizes proprietary MitoXcel™ Technology to restore mitochondrial function and promote the clearance of senescent cells, aiming to improve healthspan and address age-related diseases. This context-dependent approach intervenes at the root cause of aging, mitochondrial dysfunction, to drive systemic improvements.

Technology stack

detected 2026-06-16
Est. monthly stack spend~$160/mo
CDN
Cloudflare
EmailMicrosoft 365
Stack
jQueryWordPress
Analytics
Google Analytics 4
SEO
All in One SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Eos SENOLYTIX, . do?

Eos SENOLYTIX is a longevity biotechnology company developing novel gerotherapeutics that target the fundamental mechanisms of aging. Their lead candidate, PTC-2105, utilizes proprietary MitoXcel™ Technology to restore mitochondrial function and promote the clearance of senescent cells, aiming to improve healthspan and address age-related diseases. This context-dependent approach intervenes at the root cause of aging, mitochondrial dysfunction, to drive systemic improvements.

How much funding has Eos SENOLYTIX, . raised?

Eos SENOLYTIX, . has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Eos SENOLYTIX, . headquartered?

Eos SENOLYTIX, . is headquartered in Cambridge, United States.

When was Eos SENOLYTIX, . founded?

Eos SENOLYTIX, . was founded in 2017.

What industry does Eos SENOLYTIX, . operate in?

Eos SENOLYTIX, . operates in Biotech, MedTech, HealthTech, Longevity, Senolytics, Drug Discovery.